Rise Health, an Arlington, VA-based healthcare company focused on the treatment of Type 2 Diabetes, raised $6.5M in Series A funding.
The round was led by Route 66 Ventures with participation from W Health and Healthworx.
The company intends to use the funds to continue to grow its team, strengthen its business operations, partner with like-minded organizations, and expand into new markets.
Founded in 2021 and led by CEO Richard Gurley, Ryse Health leverages a physician-led interdisciplinary care model that includes both in- person visits with tech-enabled virtual care. The company designed and built a new approach to treating Type 2 Diabetes that aims to deliver results for patients by 1) providing day-to-day support, analytics, and coaching to ensure continued success; 2) using continuous glucose monitors and long-term support via its custom app; and, 3) a team of endocrinologists, diabetes educators, dietitians, behavioral therapists, and health coaches all supporting patients’ personalized care plan.
The company operates low-cost clinics in Arlington, VA, and Baltimore.